<--- Back to Details
First PageDocument Content
Chemistry / Clinical medicine / Organic chemistry / MEK inhibitor / Protein kinase inhibitors / B-Raf inhibitor / Sulfonamides / Vemurafenib / Cobimetinib / Keratoacanthoma / Ofloxacin
Date: 2015-11-10 11:42:30
Chemistry
Clinical medicine
Organic chemistry
MEK inhibitor
Protein kinase inhibitors
B-Raf inhibitor
Sulfonamides
Vemurafenib
Cobimetinib
Keratoacanthoma
Ofloxacin

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 719,43 KB

Share Document on Facebook

Similar Documents

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use COTELLIC safely and effectively. See full prescribing information for COTELLIC. COTELLIC (cobimetinib) tablets, for

DocID: 1pQS7 - View Document

TRXE-009-1, an investigational small molecule, significantly inhibits tumour growth and extends survival in vivo. Eleanor I. Ager1, Dhanalakshmi Sivanandhan2, Ram Sudheer Adluri3, Alex Stevenson4, Eleanor Eiffe1, Andrew

TRXE-009-1, an investigational small molecule, significantly inhibits tumour growth and extends survival in vivo. Eleanor I. Ager1, Dhanalakshmi Sivanandhan2, Ram Sudheer Adluri3, Alex Stevenson4, Eleanor Eiffe1, Andrew

DocID: 1pi8T - View Document